Anti-CD20-CAR-transduced T cells
TMMU-BTC-003
Phase 2 mab active
Quick answer
Anti-CD20-CAR-transduced T cells for Leukemia is a Phase 2 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Leukemia
- Phase
- Phase 2
- Modality
- mab
- Status
- active